|
1
|
Hartley JL, Davenport M and Kelly DA:
Biliary atresia. Lancet. 374:1704–1713. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mieli-Vergani G and Vergani D: Biliary
atresia. Semin Immunopathol. 31:371–381. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sira MM, Taha M and Sira AM: Common
misdiagnoses of biliary atresia. Eur J Gastroenterol Hepatol.
26:1300–1305. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
You Z, Wen J, Cheng L, Ye H and Li B:
Screening of targeted genes in extrahepatic bile ducts of mice with
experimental biliary atresia. Mol Med Rep. 12:4326–4331. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zagory JA, Nguyen MV and Wang KS: Recent
advances in the pathogenesis and management of biliary atresia.
Curr Opin Pediatr. 27:389–394. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li Y, Wu Q, Wang Y, Li L, Bu H and Bao J:
Senescence of mesenchymal stem cells (Review). Int J Mol Med.
39:775–782. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang H, Zhang H, Huang B, Miao G, Yan X,
Gao G, Luo Y, Chen H, Chen W and Yang L: Mesenchymal stem cells
reverse highfat dietinduced nonalcoholic fatty liver disease
through suppression of CD4+ T lymphocytes in mice. Mol Med Rep.
17:3769–3774. 2018.PubMed/NCBI
|
|
8
|
Sioud M, Mobergslien A, Boudabous A and
Floisand Y: Mesenchymal stem cell-mediated T cell suppression
occurs through secreted galectins. Int J Oncol. 38:385–390. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Berardis S, Lombard C, Evraerts J, El
Taghdouini A, Rosseels V, Sancho-Bru P, Lozano JJ, van Grunsven L,
Sokal E and Najimi M: Gene expression profiling and secretome
analysis differentiate adult-derived human liver stem/progenitor
cells and human hepatic stellate cells. PLoS One. 9:e861372014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang R, Lin Z, Lui VCH, Wong KKY, Tam
PKH, Lee P, Lok CN, Lamb JR, Chen Y and Xia H: Silver nanoparticle
treatment ameliorates biliary atresia syndrome in rhesus rotavirus
inoculated mice. Nanomedicine. 13:1041–1050. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rojas M, Xu J, Woods CR, Mora AL, Spears
W, Roman J and Brigham KL: Bone marrow-derived mesenchymal stem
cells in repair of the injured lung. Am J Respir Cell Mol Biol.
33:145–152. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mohanty SK, Donnelly B, Dupree P, Lobeck
I, Mowery S, Meller J, McNeal M and Tiao G: A point mutation in the
rhesus rotavirus VP4 protein generated through a rotavirus reverse
genetics system attenuates biliary atresia in the murine model. J
Virol. 91:e005102017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bezerra JA: Potential etiologies of
biliary atresia. Pediatr Transplantat. 9:646–651. 2005. View Article : Google Scholar
|
|
14
|
Petersen C, Grasshoff S and Luciano L:
Diverse morphology of biliary atresia in an animal model. J
Hepatol. 28:603–607. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Riepenhoff-Talty M, Schaekel K, Clark HF,
Mueller W, Uhnoo I, Rossi T, Fisher J and Ogra PL: Group A
rotaviruses produce extrahepatic biliary obstruction in orally
inoculated newborn mice. Pediatr Research. 33:394–399. 1993.
View Article : Google Scholar
|
|
16
|
Elmahdy NA, Sokar SS, Salem ML, Sarhan NI
and Abou-Elela SH: Anti-fibrotic potential of human umbilical cord
mononuclear cells and mouse bone marrow cells in CCl4- induced
liver fibrosis in mice. Biomed Pharmacother. 89:1378–1386. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cadenas E: Biochemistry of oxygen
toxicity. Annu Rev Biochem. 58:79–110. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Asakawa T, Tanaka Y, Asagiri K, Kobayashi
H, Tanikawa K and Yagi M: Oxidative stress profile in the
post-operative patients with biliary atresia. Pediatr Surg Int.
25:93–97. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tang N, Zhang Y, Liu Z, Fu T, Liang Q and
Ai X: Correlation analysis between four serum biomarkers of liver
fibrosis and liver function in infants with cholestasis. Biomed
Rep. 5:107–112. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Baranova A, Lal P, Birerdinc A and
Younossi ZM: Non-invasive markers for hepatic fibrosis. BMC
Gastroenterol. 11:912011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang B, Komers R, Carew R, Winbanks CE, Xu
B, Herman-Edelstein M, Koh P, Thomas M, Jandeleit-Dahm K,
Gregorevic P, et al: Suppression of microRNA-29 expression by
TGF-β1 promotes collagen expression and renal fibrosis. J Am Soc
Nephrol. 23:252–265. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Williams EJ, Benyon RC, Trim N, Hadwin R,
Grove BH, Arthur MJ, Unemori EN and Iredale JP: Relaxin inhibits
effective collagen deposition by cultured hepatic stellate cells
and decreases rat liver fibrosis in vivo. Gut. 49:577–583. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jiang XX, Zhang Y, Liu B, Zhang SX, Wu Y,
Yu XD and Mao N: Human mesenchymal stem cells inhibit
differentiation and function of monocyte-derived dendritic cells.
Blood. 105:4120–4126. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jang YO, Jun BG, Baik SK, Kim MY and Kwon
SO: Inhibition of hepatic stellate cells by bone marrow-derived
mesenchymal stem cells in hepatic fibrosis. Clin Mol Hepatol.
21:141–149. 2015. View Article : Google Scholar : PubMed/NCBI
|
